Erika Tamabuchi Selected Research

Erika Tamabuchi Research Topics

4	Melanoma (Melanoma, Malignant) 12/2023 - 02/2018
3	Neoplasms (Cancer) 04/2024 - 09/2021
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2023 - 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 12/2023
1	Uveitis 12/2023
1	Hemangiosarcoma (Angiosarcoma) 11/2023
1	Skin Neoplasms (Skin Cancer) 11/2023
1	Mycosis Fungoides 11/2022
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 05/2022
1	Rheumatoid Arthritis 05/2022
1	COVID-19 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Drug Eruptions (Drug Eruption) 01/2022
1	Monoclonal Gammopathy of Undetermined Significance 09/2021
1	Cutis Laxa 09/2021
1	Microcystic adnexal carcinoma 09/2021
1	Multifocal fibrosclerosis 06/2021
1	Localized Scleroderma (Morphea) 06/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Lichen Planus (Lichen Ruber Planus) 01/2021
1	Erythema 02/2018
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 09/2014
1	Seborrheic Keratosis 05/2014

3	Bexarotene (LGD1069)FDA Link 06/2023 - 01/2022
2	pembrolizumabIBA 04/2024 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 05/2022
2	dabrafenibIBA 05/2022 - 02/2018
2	trametinibIBA 05/2022 - 02/2018
2	NivolumabIBA 01/2022 - 02/2018
1	HLA-DRB1*04 antigenIBA 12/2023
1	Proto-Oncogene Proteins B-rafIBA 12/2023
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2023
1	Plasminogen Activator Inhibitor 1IBA 11/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2023
1	binimetinibIBA 05/2022
1	encorafenibIBA 05/2022
1	RetinoidsIBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 09/2021
1	PeriostinIBA 09/2021
1	Matrix Metalloproteinases (MMPs)IBA 09/2021
1	Immunoglobulins (Immunoglobulin)IBA 06/2021
1	InterferonsIBA 09/2014
1	Melanins (Melanin)IBA 05/2014